CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrants to purchase common stock | +8,649 | 8,649 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrants to purchase common stock | +89,600 | 89,600 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrants to purchase common stock | +89,600 | 89,600 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrants to purchase common stock | +82,461 | 82,461 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | +89,600 | 89,600 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | −1,010 | 0 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrants to purchase common stock | −8,649 | 0 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | −89,600 | 0 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | −89,600 | 0 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | −82,461 | 0 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | −89,600 | 0 | ||
| 2020-08-20 | Johnson Bankole A. Chief Medical Officer | Sale | −350,000 | $1.21 | $424K | 1,055 |
| 2020-05-19 | REICH JACK W Director | Grant or award · Stock Option | +90,000 | 90,000 | ||
| 2020-03-27 | Newman James W. Jr. Director | Purchase | +5,000 | $1.42 | $7K | 15,000 |
| 2020-03-27 | Newman James W. Jr. Director | Purchase | +10,000 | $1.34 | $13K | 13,288 |
| 2020-03-27 | Newman James W. Jr. Director | Purchase | +4,644 | $1.35 | $6K | 14,644 |
| 2020-03-26 | Stilley William B. III Chief Executive Officer | Purchase | +12,652 | $1.47 | $19K | 715,937 |
| 2020-03-25 | Stilley William B. III Chief Executive Officer | Purchase | +12,348 | $1.13 | $14K | 703,285 |
| 2020-03-03 | Gilliland Robertson H. Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2020-03-03 | Schuyler Kevin Director | Grant or award · Stock Option | +60,000 | 60,000 |
Page 6 of 10 · 190 trades